Showing 2231-2240 of 9355 results for "".
- Difficult Psoriasis Cases Highlight Systemic Disease, Combination Therapy, and Precision Treatment at Science of Skin Summithttps://practicaldermatology.com/news/difficult-psoriasis-cases-highlight-systemic-disease-combination-therapy-and-precision-treatment-at-science-of-skin-summit/2488530/Modern psoriasis management increasingly requires dermatologists to look beyond visible plaques and consider the systemic disease, individual comorbidities, treatment history, and potentially even a patient's molecular profile.
- FDA Approves First Treatment for Ataxia-Telangiectasiahttps://practicaldermatology.com/news/fda-approves-first-treatment-for-ataxia-telangiectasia/2488536/The US Food and Drug Administration (FDA) has approved Aqneursa (levacetylleucine; IntraBio) for the treatment of adults and pediatric patients with ataxia-telangiectasia (A-T) who weigh at least 15 kg, providing the first FDA-approved treatment for the rare multisystem disorder. A-T is pr
- Expert Consensus Defines Best Practices for Pseudofolliculitis Barbaehttps://practicaldermatology.com/news/expert-consensus-defines-best-practices-for-pseudofolliculitis-barbae/2488539/A new expert consensus study published online in JAMA Dermatology outlines best practices for diagnosing and managing pseudofolliculitis barbae (PFB), including hair removal modification, medical therapy, procedural treatment, and occupational considerations.
- Google Employee Discusses AI Reshaping How Patients Search for Skincare Informationhttps://practicaldermatology.com/news/google-employee-discusses-ai-reshaping-how-patients-search-for-skincare-information/2488527/Artificial intelligence (AI) is changing not only where patients seek information about skin health and aesthetics but also how they formulate their questions and move from initial research to clinical decisions.
- Zasocitinib Could Raise the Efficacy Bar for Oral Psoriasis Treatment, Takeda Doctor Sayshttps://practicaldermatology.com/news/zasocitinib-could-raise-the-efficacy-bar-for-oral-psoriasis-treatment-takeda-doctor-says/2488520/Following the US Food and Drug Administration's decision to grant Priority Review to zasocitinib (TAK-279) for adults with moderate-to-severe plaque psoriasis, Chinwe Ukomad
- Risankizumab, Ustekinumab Linked to Lower Infection Risk in Psoriasishttps://practicaldermatology.com/news/risankizumab-ustekinumab-linked-to-lower-infection-risk-in-psoriasis/2488488/Biologics and small molecules used in psoriasis therapies had a favorable safety profile, according to new research in the Journal of Investigative Dermatology. Study researchers included 4,820 patients (8,826 treatment cycles; 20,829 patient years of follow-up) in the analysis.
- Anzupgo Receives Positive CHMP Opinion for Adolescent CHEhttps://practicaldermatology.com/news/anzupgo-receives-positive-chmp-opinion-for-adolescent-che/2488490/The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the indication for Anzupgo (delgocitinib) cream to adolescents aged 12 to 17 years with moderate to severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or i
- Dupilumab, Tralokinumab Supported by Review of Nummular Eczema Treatmentshttps://practicaldermatology.com/news/dupilumab-tralokinumab-supported-by-review-of-nummular-eczema-treatments/2488484/A new systematic review found evidence supporting several biologic and small-molecule treatment options for nummular eczema despite a lack of FDA-approved therapies. Dupilumab, T
- Dupilumab Shows Sustained Effectiveness Through 3 Years in Pediatric Atopic Dermatitis: Analysishttps://practicaldermatology.com/news/dupilumab-shows-sustained-effectiveness-through-3-years-in-pediatric-atopic-dermatitis-analysis/2488475/Dupilumab demonstrated sustained effectiveness and a 3-year drug survival rate of 80.1% among pediatric patients with moderate to severe atopic dermatitis (AD) in a prospective real-world cohort published in JAMA Derma
- Sun Pharma Partners with Christian Siriano for Alopecia Areata Awareness Campaignhttps://practicaldermatology.com/news/sun-pharma-partners-with-christian-siriano-for-alopecia-areata-awareness-campaign/2488473/Sun Pharma announced a partnership with fashion designer Christian Siriano on "Regrowth Restyled," a new awareness campaign focused on confidence, self-expression and hair growth support for adults living with severe alopecia areata. Launched during Alopecia Areata Awareness Month, the cam